Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
GVS reports stable growth in Q3 2025 with stronger healthcare and safety performance
GVS recorded stable revenue growth in the third quarter of 2025, driven by a 4.8% increase in healthcare and 8.5% in safety. Adjusted net income rose 7.2% to €36.3 million and the adjusted EBITDA margin improved to nearly 25%. Management announces expansions in China and the USA, operational optimizations and new MedTech products for 2026, but expects only low single-digit constant‑currency revenue growth for 2025 and an EBITDA improvement of 100–150 basis points. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 110.06m | 1.54% |
| Gross profit | 10.73m | 85.84% |
| Net profit | 11.97m | 1,498.01% |
| EBITDA | 32.74m | 155.67% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €986.04m |
Number of shares | 187.46m |
52-week high/low | €5.48 - €3.32 |
| Dividends | No |
Beta | 1.06 |
P/E ratio | 23.42 |
PEG ratio | 0.15 |
P/B ratio | 2.03 |
P/S ratio | 2.33 |
Company profile
GVS S.p.A., together with its subsidiaries, produces and sells filter solutions for applications in the healthcare and life science, energy and mobility, and health and safety sectors in Italy and internationally. The company offers health and safety products, such as hand dryer and vacuum cleaner filters; double nailstation, kidney nailstation, rectangle nail station with storage cupboard, and rectangular nailstation products; fume extraction and HVAC building products; and disposable masks, half masks, integra masks, powered air purifying respirators, replacement filters, supplied air respirators, spare parts, and accessories. It also provides autoclave filters, insufflation and ventilation filters and kits, machine filters, respiratory and anesthesia filters, smoke evacuation filters and kits, spirometry filters and accessories, suction filters, and tracheal humidifier filters; healthcare liquid products, such as bacterial air vents, blood filters, infusion disc filters, IV and liquid filters, IV flow regulators, medical components, transducer protectors; and capsule and cartridge filters, disc and sheet membranes, DNA/RNA test kits, filter papers, microbiology products, microfiltration devices, microporous and track etched roll membranes, protein microarrays, and environmental monitoring and western blotting products. In addition, the company offers energy and mobility products, such as fuel tank and fuel pump filters, gears, throttle plates and shafts, reservoir filters, SCR urea systems; ABS, ESP, and brake systems; EV applications and batteries; injection, tank vapour ventilation, and transmission products; ventilation systems; and viral shield cabin air and engine air intake filters. GVS S.p.A. was formerly known as GVS S.r.l. and changed its name to GVS S.p.A. in 2001. The company was founded in 1979 and is headquartered in Zola Predosa, Italy. GVS S.p.A. is a subsidiary of GVS Group S.p.A.
| Name | GVS SpA Ordinary Shares |
| CEO | Massimo Scagliarini |
| Headquarters | Zola Predosa,
bo Italy |
| Website | |
| IPO | 19/06/2020 |
| Employees | 3,952 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Mil | GVS.MI |
Frankfurt | 4YQ.F |
Düsseldorf | 4YQ.DU |
Milan | GVS.MI |
London | 0GV5.L |
München | 4YQ.MU |